Streptokinase is more economical than alteplase

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1506 (Published 02 December 1995) Cite this as: BMJ 1995;311:1506
  1. J C Mucklow, Senior lecturer (clinical pharmacology)
  1. Department of Pharmacy Policy and Practice, Keele University, Keele ST5 5BG

    EDITOR,--Marc Verstraete cites streptokinase and alteplase as alternative thrombolytic drugs for the management of myocardial infarction.1 His guidance on choice is confined to the statement that …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription